首页|参芪扶正注射液辅助替吉奥、奥沙利铂治疗进展期胃癌的效果

参芪扶正注射液辅助替吉奥、奥沙利铂治疗进展期胃癌的效果

扫码查看
目的:探究参芪扶正注射液辅助替吉奥、奥沙利铂治疗进展期胃癌的效果。方法:回顾性分析 2018 年 9 月—2023 年 9 月中国人民解放军东部战区总医院肿瘤中心收治的 400 例进展期胃癌患者。根据不同治疗方案将其分为对照组(n=200)和观察组(n=200)。对照组给予替吉奥、奥沙利铂治疗,观察组在对照组基础上增加参芪扶正注射液辅助治疗。比较两组临床疗效,治疗前及治疗 4 个疗程后肿瘤标志物、免疫功能、生活质量及不良反应。结果:观察组客观缓解率、疾病控制率均高于对照组,差异有统计学意义(P<0。05)。治疗 4 个疗程后,两组癌抗原 125(CA125)、神经元特异性烯醇化酶(NSE)、细胞角蛋白 19 片段(CYFRA21-1)、组织多肽特异性抗原(TPS)水平均降低,观察组CA125、NSE、CYFRA21-1、TPS水平均低于对照组,差异有统计学意义(P<0。05)。治疗 4 个疗程后,两组CD3+、CD4+、CD4+/CD8+均降低,观察组CD3+、CD4+、CD4+/CD8+均高于对照组,差异有统计学意义(P<0。05)。治疗 4 个疗程后,两组躯体、生理、心理、社会评分均升高,观察组躯体、生理、心理、社会评分均高于对照组,差异有统计学意义(P<0。05)。两组恶心呕吐、骨髓抑制、腹泻、神经毒性反应发生率比较,差异无统计学意义(P>0。05)。结论:进展期胃癌患者采用参芪扶正注射液辅助替吉奥、奥沙利铂治疗效果显著,可降低血清肿瘤标记物水平,改善免疫功能,提高生活质量,用药安全。
Effect of Shenqi Fuzheng Injection Assisted with Tiggio and Oxaliplatin in the Treatment of Advanced Gastric Cancer
Objective:To explore the effect of Shenqi Fuzheng Injection assisted with Tiggio and Oxaliplatin in the treatment of advanced gastric cancer.Method:A retrospective analysis was performed on 400 patients with advanced gastric cancer admitted to the Cancer Center of Chinese People's Liberation Army Eastern Theater Command General Hospital from September 2018 to September 2023.They were divided into control group(n=200)and observation group(n=200)according to different treatment plans.The control group was treated with Tiggio and Oxaliplatin,and the observation group was treated with Shenqi Fuzheng Injection on the basics of control group.The clinical efficacy,tumor markers,immune function,quality of life before treatment and after 4 courses of treatment and adverse reactions were compared between the two groups.Result:The objective remission rate and disease control rate of the observation group were higher than those of the control group,and the differences were statistically significant(P<0.05).After 4 courses of treatment,the levels of cancer antigen 125(CA125),neuron specific enolase(NSE),cytokeratin 19 fragment(CYFRA21-1)and tissue polypeptide-specific antigen(TPS)in both groups were decreased,and the levels of CA125,NSE,CYFRA21-1 and TPS in the observation group were lower than those in the control group,the differences were statistically significant(P<0.05).After 4 courses of treatment,CD3+,CD4+,CD4+/CD8+were decreased in both groups,and CD3+,CD4+,CD4+/CD8+in the observation group were higher than those in the control group,the differences were statistically significant(P<0.05).After 4 courses of treatment,the physical,physiological,psychological and social scores of the two groups were increased,and the physical,physiological,psychological and social scores of the observation group were higher than those of the control group,the differences were statistically significant(P<0.05).There were no significant difference in the incidences of nausea and vomiting,myelosuppression,diarrhea and neurotoxicity between the two groups(P>0.05).Conclusion:In patients with advanced gastric cancer,Shenqi Fuzheng Injection assist with Tiggio and Oxaliplatin treatment has significant therapeutic effect,which can reduce the level of serum tumor markers,improve immune function,improve quality of life and drug safety.

Advanced gastric cancerShenqi Fuzheng InjectionTiggioOxaliplatin

姚琳、曲文书

展开 >

中国人民解放军东部战区总医院 江苏 南京 210002

进展期胃癌 参芪扶正注射液 替吉奥 奥沙利铂

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(26)